Navigation Links
New way of tracking muscle damage from radiation

Magnetic resonance imaging (MRI) could become a valuable tool for predicting the risk of muscle injury during and following radiation therapy, according to investigators at St. Jude Children's Research Hospital.

The researchers report that MRI can spot the immediate injury done by radiation therapy to the muscles of children undergoing radiation treatment for certain types of soft-tissue cancer. This also indicates that MRI might one day be able to help doctors predict the amount of long-term damage that radiation may cause. A report on these findings appears in the Oct. 25 online issue of Magnetic Resonance Imaging.

The study's findings are significant because as radiation treatments become more advanced and complex, clinicians must have a way to predict the outcomes--including side effects--on specific patients, according to Matthew Krasin, M.D., associate member of the St. Jude Department of Radiological Sciences.

The St. Jude study showed that changes in images taken of muscles before and after radiation therapy for soft tissue sarcoma and Ewing sarcoma are related not only to the amount of radiation the child received, but also to the child's age and the presence of a nearby tumor.

"We hope that detecting these changes at such an early stage may help clinicians predict which patients need an intervention to prevent late damage," Krasin said. Soft tissue sarcomas are cancers that arise in muscles, fat, blood vessels and other soft tissues. Ewing sarcoma is a cancer that arises in the bone or soft tissue, usually in the arms, legs, pelvis or chest wall.

St. Jude researchers studied the muscles of 13 patients before, during and 12 weeks after they received radiation therapy for soft tissue sarcoma. The team used a technique called quantitative T2 to determine the extent of swelling in tissues before, during and after radiation therapy; and a technique called dynamic enhanced magnetic resonance imaging (DEMRI) to
'"/>

Source:St. Jude Children's Research Hospital


Page: 1 2

Related biology news :

1. Findings have implications for tracking disease, drugs at the molecular level
2. Radio-tracking associated with dramatic shift in water vole sex ratio
3. UQ researcher tracking key to healing the brain
4. Concern over fast tracking of new drugs
5. How satellite tracking revealed the migratory mysteries of endangered Atlantic loggerhead turtles
6. Heart repair gets new muscle
7. Small worm yields big clue on muscle receptor action
8. New complete muscle grown in the lab
9. Spiders help scientists discover how muscles relax
10. Cant serve an ace? Could be muscle fatigue
11. Lance Armstrong through a physiological lens: hard training boosts muscle power 8%

Post Your Comments:
(Date:11/30/2009)...er thought the stress of seeing your extended fami...s: a new research report in the December 2009 prin...tp://www.jleukbio.org ) shows that you might be ri...tudy might lead to entirely new treatments that he... and eczema under control. That,s because research...
(Date:11/30/2009)...s a colorless and odorless radioactive gas that is...um is a product of uranium decay and is found in t... and groundwater as well as building materials, pl...entration is expressed as the amount of radiation ...cts in a liter of air; thus the units are picocuri...
(Date:11/26/2009)...s have at last worked out a way of using recording...rd populations. This is the first time sound recor... into accurate estimates of bird species, populati...itish Ecological Society,s Journal of Applied Eco...ad to a major advance in our ability to monitor wh...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Ecologists sound out new solution for monitoring cryptic species 2Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 1Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 2Psoriasis Raises Risk of Heart Attack Stroke Death 48954 1Psoriasis Raises Risk of Heart Attack Stroke Death 48954 2MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 1MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 2
...ub-Saharan Africa, according to the World Health O...nst the virus have achieved limited success. But w...ted infection found widely in that region of Afric...ould reduce transmission of HIV as much as 10-fold... from the University of North Carolina at Chapel H...
...era enables shorter image acquisition times, provi... diagnostic procedures using simultaneous multi-is...onize functional imaging, according to results rel...Diego. , "The potential of using more than one tr...s that more than one medical condition can be sear...
...lls of the immune system has been discovered at Th...nowledge, medical researchers can begin to conside...sing this new cell to target specific infections s... and even autoimmune diseases. , Dendritic cells (...atrol the body, searching for infections. DC seize...
Other Biology News:Vaccine shown effective against chancroid 2Vaccine shown effective against chancroid 3Patients to benefit from novel technology revolutionizing high-speed molecular imaging 2Patients to benefit from novel technology revolutionizing high-speed molecular imaging 3Knowledge of dendritic cells branches out 2
(Date:11/30/2009)..., ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ -...t has completed enrollment in the Phase II clinica...2009 recommended strains) VLP vaccine candidate in...ults). This randomized, double-blind, active-cont... and immunogenicity of two different doses (15 mcg...
(Date:11/30/2009)... , SEATTLE, Nov. 30 ...C) announced today that its new class of platinum-... demonstrated a stronger anti-tumor potency and ac...sed compounds as well as the ability to overcome c...ults were presented in a paper titled "Novel Bis-p...
(Date:11/30/2009)... , LONDON, November 30 ...y, was named Europe,s fastest growing,Biotech/Phar... the Deloitte,2009 Technology Fast 500 for EMEA (E...nual ranking is based on a companies, five-year re...e of 8,318% over this period. This,achievement pla...
(Date:11/28/2009)... The Vanuatu National Advisory Commi...National Communication (SNC) Project in collaborat...LIMsystems Ltd. of New Zealand have generated prel...that will form the background for the country&rsqu...Convention on Climate Change (UNFCCC). , ...
Breaking Biology Technology:NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...aceuticals,Inc. (Nasdaq: ARNA ) announced today t...ts with Siegfried Ltd., an affiliate of Siegfried,...elate to the,manufacturing of lorcaserin hydrochlo...s planned New Drug Application (NDA) submission to...or commercialization of,lorcaserin after regulator...
...technology could eliminate animal testing in the c... curtail its use in the development of new pharmac... researchers at Rensselaer Polytechnic Institute, ...dus Biosciences Inc. , The team,s most recent di...on of the Proceedings of the National Academy of S...
... IRIDEX,Corporation (Nasdaq: IRIX ) today announc...ny as Chief Financial Officer effective January 2,...l Officer and Vice President,of Finance for NextHo...logy,company. Previously, he served as Vice Presid...oGear Technology Corp., a company that developed,a...
Other Biology Technology:Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin 2Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin 3Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin 4Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin 5Biochip mimics the body to reveal toxicity of industrial compounds 2Biochip mimics the body to reveal toxicity of industrial compounds 3IRIDEX Announces James Mackaness Will Be Chief Financial Officer 2
Mouse Anti-Plastin L Monoclonal Antibody, Unconjugated, Clone LPL4A.1 from Abcam
Mouse Anti-Chloramphenicol Acetyltransferase Monoclonal Antibody, Unconjugated, Clone CAT-1 from Abcam
...mpetent Yeast Cells are designed for use with the ...ae strain MaV203 contains deletions in the endogen...wo-hybrid systems. The strain also has leu2 and tr...ey vectors. MaV203 contains three GAL4 inducible r...
mCD-1 Multi-Probe Template Set from BD Biosciences Pharmingen
Biology Products: